A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

Chao Liu,1,2 Bing Sun,2 Bin Xu,1 Xiangying Meng,2 Lan Li,1 Yang Cong,2 Jiannan Liu,2 Qian Wang,2 Liang Xuan,2 Qibin Song,1 Shikai Wu2 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Department of Radiation Oncology, Affiliated Hospital of Academy of...

Full description

Bibliographic Details
Main Authors: Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Cancer Management and Research
Subjects:
breast cancer
immune checkpoint
PD-1
CTLA-4
IL-2Rα
diagnosis
biomarker
Online Access:https://www.dovepress.com/a-panel-containing-pd-1-il-2ralpha-il-10-and-ca15-3-as-a-biomarker-to--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/a-panel-containing-pd-1-il-2ralpha-il-10-and-ca15-3-as-a-biomarker-to--peer-reviewed-article-CMAR

Similar Items